626972-b7bc7b35-79ca-456f-a850-1a22eb49df9c
Position
President & CEO, CMO
Company
Synlogic
Location
Cambridge Massachusetts UNITED STATES
Bio
Dr. Aoife Brennan has served as Synlogic’s president and chief executive officer since October 2018 after serving as interim president and CEO from May 2018. She joined Synlogic in September 2016 as chief medical officer responsible for the oversight and direction of the company’s clinical development strategy and operations. In addition to her duties as chief executive officer, she will continue to serve as chief medical officer until a replacement is appointed. Aoife previously spent six years at Biogen, where she was in roles of increasing responsibility and most recently served as vice president and head of the Rare Disease Innovation Unit, which included programs ranging from pre-clinical to commercial. She has also led programs across multiple therapeutic areas including the late phase development of nusinersen for spinal muscular atrophy and ALPROLIX® and ELOCTATE®, treatments for Hemophilia B and Hemophilia A. Prior to joining Biogen, she was director of clinical development at Tolerx, a start-up biotech company focusing on immunotherapy for Type 1 diabetes. Aoife holds a medical degree from Trinity College in Dublin, Ireland and has completed post-graduate training in internal medicine, endocrinology and metabolism. She has completed post-doctoral training in clinical research and metabolism at the Beth Israel Deaconess Medical Center in Boston and is a graduate of the Harvard Medical School Scholars in Clinical Science Program.
Interests
None yet.